IDO1 and neoplasm: Indoleamine 2,3-dioxygenase 1 (IDO1), a heme-containing oxidoreductase that catalyzes tryptophan catabolism to kynurenine in the first rate-limiting step of the kynurenine pathway, plays an important role in tumor evasion of immune surveillance [7,8].